東北大学

東北大学大学院医学系研究科
腎・膠原病・内分泌内科学分野
東北大学病院 腎・高血圧・内分泌科

論文・著書

~歴史ある論文・著書~

2014年

論文【英文】

  1. Matsuda K, Uruno A, Kogure N, Sugawara K, Shimada H, Nezu M, Saito-Ito T, Iki Y, Kudo M, Shimizu K, Sato I, Yoshikawa T, Satoh F, Ito R, Yokoyama A, Rainey WE, Saito-Hakoda A, Ito S, Sugawara A: Angiotensin II receptor blockers differentially affect CYP11B2 expression in human adrenal H295R cells. Mol Cell Endocrinol 383:60-68, 2014
  2. Shimamoto K, Hasebe N, Ito S, Kario K, Kimura K, Dohi Y, Kawano Y, Rakugi H, Horiuchi M, Imaizumi T, Ohya Y: Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study. Hypertens Res 37(1):69-75, 2014
  3. Funabiki M, Kato H, Miyachi Y, Toki H, Motegi H, Inoue M, Minowa O, Yoshida A, Deguchi K, Sato H, Ito S, Shiroishi T, Takeyasu K, Noda T, Fujita T.  Autoimmune Disorders Associated with Gain of Function of the Intracellular Sensor MDA5. Immunity 40(2):199-212, 2014
  4. Doi M, Satoh F, Maekawa T, Nakamura Y, Fustin JM, Tainaka M, Hotta Y, Takahashi Y, Morimoto R, Takase K, Ito S, Sasano H, Okamura H: Isoform-specific monoclonal antibodies against 3β-hydroxysteroid dehydrogenase/isomerase family provide markers for subclassification of human primary aldosteronism. J Clin Endocrinol Metab. 99(2); E257-262, 2014
  5. Sato H, Takahashi N, Sato E, Kisu K, Ito S, Saito T: Pathology of glomerular lipidosis; Clin Exp Nephrol 18(2):194-196, 2014
  6. Iwakura Y, Morimoto R, Kudo M, Ono Y, Takase K, Seiji K, Arai Y, Nakamura Y, Sasano H, Ito S, Satoh F. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: Renal outcome of 213 cases. J Clin Endocrinol Metab 99(5):1593-1598, 2014
  7. Terawaki H, Zhu WJ, Matsuyama Y, Terada T, Takahashi Y, Sakurai K, Kabayama S, Miyazaki M, Itami N, Nakazawa R, Ito S, Era S, Nakayama M: Effect of a hydrogen (H2 )-enriched solution on the albumin redox of hemodialysis patients. Hemodial Int 18(2):459-466, 2014
  8. Phaeochromocytoma Study Group in Japan, Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M: Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer 21(3):405-414, 2014
  9. Kimura N, Takekoshi K, Horii A, Morimoto R, Imai T, Oki Y, Saito T, Midorikawa S, Arao T, Sugisawa C, Yamada M, Otuka Y, Kurihara I, Sugano K, Nakane M, Fukuuchi A, Kitamoto T, Saito J, Nishikawa T, Naruse M: Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma. Endocr Relat Cancer 21(3):L13-16, 2014
  10. Kudo M, Matsuda K, Sugawara K, Iki Y, Kogure N, Saito-Ito T, Shimizu K, Sato I, Yoshikawa T, Uruno A, Ito R, Yokoyama A, Saito-Hakoda A, Ito S, Sugawara A: ARB affects nicotine-induced gene expression profile in human coronary artery endothelial cells; World J Hypertens 4(1); 7-14, 2014
  11. Hashimoto J: Central Hemodynamics and Target Organ Damage in Hypertension; Tohoku J Exp Med 233; 1-8, 2014
  12. Mishima E, Inoue C, Saigusa D, Inoue R, Ito K, Suzuki Y, Jinno D, Tsukui Y, Akamatsu Y, Araki M, Araki K, Shimizu R, Shinke H, Suzuki T, Takeuchi Y, Shima H, Akiyama Y, Toyohara T, Suzuki C, Saiki Y, Tominaga T, Miyagi S, Kawagisihi N, Soga T, Ohkubo T, Yamamura K, Imai Y, Masuda S, Sabbisetti V, Ichimura T, Mount DB, Bonventre JV, Ito S, Tomioka Y, Itoh K, Abe T: Conformational Change in Transfer RNA Is an Early Indicator of Acute Cellular Damage; J Am Soc Nephrol 25(10); 2316-2326, 2014
  13. Kudo M, Satoh F, Aoki S, Morimoto R, Iwakura Y, Ono Y, Matsuda K, Sugawara A, Yoshida K, Sato K, Ito S: Assisting the diagnosis of Cushing syndrome by pattern recognition methods, using a combination of eight routine tests and their multiple correlation with serum cortisol; Biomedicine & Aging Pathology 4; 257-264, 2014
  14. Ono Y, Nakamura Y, Maekawa T, Felizola SJ, Morimoto R, Iwakura Y, Kudo M, Seiji K, Takase K, Arai Y, Gomez-Sanchez CE, Ito S, Sasano H, Satoh F: Different expression of 11β-hydroxylase and aldosterone synthase between aldosterone-producing microadenomas and macroadenomas. Hypertension 64(2):438-44, 2014
  15. Nakamura Y, Maekawa T, Felizola SJ, Satoh F, Qi X, Velarde-Miranda C, Plonczynski MW, Ise K, Kikuchi K, Rainey WE, Gomez-Sanchez EP, Gomez-Sanchez CE, Sasano H. Adrenal CYP11B1/2 expression in primary aldosteronism: Immunohistochemical analysis using novel monoclonal antibodies. Mol Cell Endocrinol ;392(1-2):73-79, 2014
  16. Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, Satoh F, Young WF Jr, Rossi GP. Response to implementation of rapid cortisol during adrenal vein sampling. Hypertension 63(4):e89, 2014
  17. Nakamura Y, Hattangady NG, Ye P, Satoh F, Morimoto R, Ito-Saito T, Sugawara A, Ohba K, Takahashi K, Rainey WE, Sasano H. Aberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA). Mol Cell Endocrinol. 384(1-2):102-8, 2014
  18. Felizola SJ, Nakamura Y, Ono Y, Kitamura K, Kikuchi K, Onodera Y, Ise K, Takase K, Sugawara A, Hattangady N, Rainey WE, Satoh F, Sasano H. PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues. J Mol Endocrinol 52(2):159-67, 2014
  19. Gomez-Sanchez CE, Qi X, Velarde-Miranda C, Plonczynski MW, Parker CR, Rainey W, Satoh F, Maekawa T, Nakamura Y, Sasano H, Gomez-Sanchez EP. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol. 383(1-2):111-7, 2014
  20. Takanami K, Kaneta T, Morimoto R, Satoh F, Nakamura Y, Takase K, Takahashi S. Characterization of lipid-rich adrenal tumors by FDG PET/CT: Are they hormone-secreting or not? Ann Nucl Med 28(2):145-53, 2014
  21. Felizola SJ, Nakamura Y, Arata Y, Ise K, Satoh F, Rainey WE, Midorikawa S, Suzuki S, Sasano H. Metallothionein-3 (MT-3) in the Human Adrenal Cortex and its Disorders. Endocr Pathol 25(3):229-235, 2014
  22. Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, Satoh F, Young WF Jr. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 63(1):151-6, 2014
  23. Felizola SJ, Nakamura Y, Satoh F, Morimoto R, Kikuchi K, Nakamura T, Hozawa A, Wang L, Onodera Y, Ise K, McNamara KM, Midorikawa S, Suzuki S, Sasano H. Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: the metabotropic pathway. Mol Cell Endocrinol 382(1):170-7, 2014
  24. Miyake Y, Tanaka K, Nishikawa T, Naruse M, Takayanagi R, Sasano H, Takeda Y, Shibata H, Sone M, Satoh F, Yamada M, Ueshiba H, Katabami T, Iwasaki Y, Tanaka H, Tanahashi Y, Suzuki S, Hasegawa T, Katsumata N, Tajima T, Yanase T. Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study. Endocr J 61(1):35-40, 2014
  25. Kato J, Nakayama M, Zhu WJ, Yokoo T, Ito S: Ischemia/Reperfusion of Unilateral Kidney Exaggerates Aging-Induced Damage to the Heart and Contralateral Kidney. Nephron Exp Nephrol 126(4):183-190, 2014
  26. Ogihara T, Saruta T, Rakugi H, Saito I, Shimamoto K, Matsuoka H, Shimada K, Ito S, Horiuchi M, Imaizumi T, Takishita S, Higaki J, Katayama S, Kimura G, Umemura S, Ura N, Hayashi K, Odawara M, Tanahashi N, Ishimitsu T, Kashihara N, Morita S, Teramukai S; COLM Investigators: Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial1. J Hypertens 32(10):2054-2063, 2014
  27. Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M, and Phaeochromocytoma Study Group in Japan; Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma; Endocrine-Related Cancer 21(3); 405-414, 2014
  28. Hashimoto J, Ito S: Central pulse pressure links microalbuminuria with plasma B type natriuretic peptide elevation: causal implication for cardiorenal syndrome in hypertension; Journal of Hypertension 32; 1665-1671, 2014
  29. Uruno A, Saito-Hakoda A, Yokoyama A, Kogure N, Matsuda K, Parvin R, Shimizu K, Sato I, Kudo M, Yoshikawa T, Kagechika H, Iwasaki Y, Ito S, Sugawara A: Retinoic acid receptor-α up-regulates proopiomelanocortin gene expression in AtT20 corticotroph cells. Endocr J 61(11):1105-1114, 2014
  30. Monticone S, Satoh F, Viola A, Fischer E, Vonend O, Bernini G, Lucatello B, Quinkler M, Ronconi V, Morimoto R, Kudo M, Degenhart C, Gao X, Carrara D, Willenberg HS, Rossato D, Mengozzi G, Riester A, Paci E, Iwakura Y, Burrello J, Maccario M, Giacchetti G, Veglio F, Ito S, Reincke M, Mulatero P: Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy. J Clin Endocrinol Metab 99(11):4158-4166, 2014
  31. Felizola SJ, Maekawa T, Nakamura Y, Satoh F, Ono Y, Kikuchi K, Aritomi S, Ikeda K, Yoshimura M, Tojo K, Sasano H: Voltage-gated calcium channels in the human adrenal and primary aldosteronism. J Steroid Biochem Mol Biol 144 Pt B:410-416, 2014
  32. Sasano H, Satoh F, Nakamura Y: Roles of the pathologist in evaluating surrogate markers for medical therapy in adrenocortical carcinoma. Endocr Pathol 25(4):366-370, 2014
  33. Nakamura Y, Felizola SJ, Satoh F, Konosu-Fukaya S, Sasano H: Dissecting the molecular pathways of primary aldosteronism. Pathol Int 64(10):482-489, 2014
  34. Sato N, Nakamura Y, Takanami K, Ono Y, Omata K, Morimoto R, Satoh F, Ise K, Yamada S, Kasajima A, Fujishima F, Watanabe M, Arai Y, Sasano H: Case report: adrenal oncocytoma associated with markedly increased FDG uptake and immunohistochemically positive for GLUT1. Endocr Pathol 25(4):410-415, 2014
  35. Felizola SJ, Nakamura Y, Ozawa Y, Ono Y, Morimoto R, Midorikawa S, Suzuki S, Satoh F, Sasano H: Activating transcription factor 3 (ATF3) in the human adrenal cortex: its possible involvement in aldosterone biosynthesis. Tohoku J Exp Med 234(4):249-254, 2014

論文【邦文】

  1. 小川晋、伊藤貞嘉:糖尿病;臨牀と研究91(1);66-71, 2014
  2. 伊藤貞嘉:高血圧治療における利尿薬の意義;SRL宝函34(4);36-44, 2014
  3. 尾股慧、伊藤貞嘉:低カリウム血症の考えかたとその対処のすすめかた;Medical Practice 31(5);748-752, 2014
  4. 伊藤貞嘉:腎疾患を合併する高血圧;治療96(5);855-857, 2014
  5. 鳴海かほり、森建文、伊藤貞嘉:免疫細胞における(プロ)レニン受容体について;Angiology Frontier 13(1);24-30, 2014
  6. 宮崎真理子、中山昌明:宮城艮陵CKD研究;医学のあゆみ248(11);864-866, 2014
  7. 宮崎真理子:災害に強い内科診療の提言 透析患者への対応(第41回内科学の展望);日本内科学会雑誌103(3);591-597, 2014
  8. 伊藤貞嘉:CKDを伴う高血圧;血圧21(5);440-444, 2014
  9. 伊藤貞嘉:うっ血腎 チェックリスト問題と解答;臨床循環器4(3);27-34, 107-111, 2014
  10. 伊藤貞嘉:進化と疾病(会長講演);日本内科学会雑誌103; 62-66, 2014
  11. 伊藤貞嘉:高血圧性腎硬化症;医学のあゆみ249(9);789-795, 2014
  12. 伊藤貞嘉:CKD合併高血圧の治療;呼吸と循環62(7);639-644, 2014
  13. 三島英換、伊藤貞嘉:合併症を有する高血圧 CKD;日本臨牀72増刊号6;454-458, 2014
  14. 森建文、小泉賢治、大場郁子、伊藤貞嘉:バソプレシンとV2受容体拮抗薬;Fluid Management Renaissance 4(3);223-232, 2014
  15. 佐藤文俊、森本玲、岩倉芳倫、小野美澄、松田謙、祢津昌広、尾股慧、工藤正孝、伊藤貞嘉:2.原発性アルドステロン症の適切な診断と治療のために;日本内科学会雑誌103(4); 886-894, 2014
  16. 伊藤貞嘉:未来の医学を創造する内科学(司会のことば)(第111回日本内科学会講演会);日本内科学会雑誌103(9);2198, 2014
  17. 伊藤貞嘉:進化と疾病(第111回日本内科学会講演会);日本内科学会雑誌103(9);2029,2014
  18. 伊藤貞嘉:Strain vessel;動脈硬化予防13(3);87-88, 2014
  19. 伊藤貞嘉:CKD合併患者;血圧21(8);714-715, 2014
  20. 伊藤貞嘉:ROADMAP;腎と透析77(4);647, 2014
  21. 山本多恵、伊藤貞嘉:Strain Vessel Theory; 内科114(3);473-475, 2014
  22. 伊藤貞嘉:脳・心・腎連関の病態;循環plus15(2);7-9, 2014
  23. 伊藤貞嘉:CKD合併高血圧の治療;Cardiac Practice 25(4); 303-307, 2014
  24. 岩倉芳倫、森本玲、工藤正孝、塚田康子、小野美澄、祢津昌広、伊藤貞嘉、佐藤文俊:原発性アルドステロン症手術治療群の術後血清カリウム値の予測因子と高K血症発症の危険因子の検討;日本内分泌学会雑誌 Vol. 90 Suppl.;58-60, 2014
  25. 岩倉芳倫 伊藤貞嘉 佐藤文俊:サイアザイド系(類似)利尿剤 ―作用機序・使用条件・病態そして最新のEBMを踏まえて適応を考える―;循環器内科, 75(3):250-257,2014
  26. 佐藤文俊、森本玲、岩倉芳倫、小野美澄、祢津昌広、松田謙、尾股慧、工藤正孝、高瀬圭、中村保宏、笹野公伸、伊藤貞嘉:二次性高血圧2.原発性アルドステロン症;最新医学69(11月増刊号);2389-2398, 2014
  27. 森本玲、清治和将、伊藤貞嘉、高瀬圭、佐藤文俊:副腎静脈サンプリングを考える:東北大学病院;ホルモンと臨床62(6);443-449, 2014

著書【分担執筆】

  1. 伊藤貞嘉:利尿薬;治療薬UP-TO-DATE 2014;矢﨑義雄監修;メディカルレビュー社;274-275, 2014.1.10
  2. 青木聡、伊藤貞嘉:5.心腎連関の系統発生的解釈;腎臓;富野康日己、柏原直樹、成田一衛編集;206-212, 2014.1.30
  3. 高橋信行、伊藤貞嘉:Bartter症候群、Gitelman症候群、Liddle症候群;腎疾患・透析最新の治療2014-2016;槇野博史、秋澤忠男、山縣邦弘編集;南江堂;217-219, 2014.3.5
  4. 山田元、伊藤貞嘉:腎障害と高血圧の関係について教えて下さい;高血圧診療Q&A115エキスパートからの回答;北風政史編集;中外医学社;166-170, 2014.3.20
  5. 阿部倫明、伊藤貞嘉:二次性高血圧;専門医のための循環器病学;小川聡、井上博、筒井裕之編集;医学書院;444-466, 2014,4,15
  6. 中山恵輔、伊藤貞嘉:メチルグリオキサールの血管障害に及ぼす影響について教えて下さい。;アンチエイジングのための100の質問;太田博明監修、山岸昌一編集;メディカルレビュー社;88-89, 2014.6.20
  7. 伊藤貞嘉:腎疾患;高血圧専門医ガイドブック改訂第3版;日本高血圧学会編集;診断と治療社;136-143, 2014.7.10
  8. 伊藤貞嘉:慢性腎臓病を伴う高齢者高血圧;高齢者高血圧の治療と管理 JSH2014改訂をふまえて;荻原俊男監修;125-128, 2014.10.20
  9. 岩倉芳倫 佐藤文俊 伊藤貞嘉:心血管合併症を有する特発性アルドステロン症-正しい診断プロセスと合併症のリスクマネジメント-;循環器疾患 治療過程で遭遇する諸問題の解決法:381-387, 2014
TOP